Abstract:Over the past few decades, substantial evidence has convincingly revealed the existence of cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly high degree of cellular heterogeneity within the tumor. CSCs are functionally defined by their abilities of self-renewal and differentiation, often in response to cues from their microenvironment. Biological phenotypes of CSCs are regulated by the integrated transcriptional, post-transcriptional, metabolic, and epigenetic regulatory networks. CSCs contribute to tumor progression, therapeutic resistance, and disease recurrence through their sustained proliferation, invasion into normal tissue, promotion of angiogenesis, evasion of the immune system, and resistance to conventional anticancer therapies. Therefore, elucidation of the molecular mechanisms that drive cancer stem cell maintenance, plasticity, and therapeutic resistance will enhance our ability to improve the effectiveness of targeted therapies for CSCs. In this review, we highlight the key features and mechanisms that regulate CSC function in tumor initiation, progression, and therapy resistance. We discuss factors for CSC therapeutic resistance, such as quiescence, induction of epithelial-to-mesenchymal transition (EMT), and resistance to DNA damage-induced cell death. We evaluate therapeutic approaches for eliminating therapy-resistant CSC subpopulations, including anticancer drugs that target key CSC signaling pathways and cell surface markers, viral therapies, the awakening of quiescent CSCs, and immunotherapy. We also assess the impact of new technologies, such as single-cell sequencing and CRISPR-Cas9 screening, on the investigation of the biological properties of CSCs. Moreover, challenges remain to be addressed in the coming years, including experimental approaches for investigating CSCs and obstacles in therapeutic targeting of CSCs.

Cancer Stemness Meets Immunity: From Mechanism to Therapy

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Cancer Stem Cell-Immune Cell Collusion in Immunotherapy.

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

Cancer stem cells: Regulation programs, immunological properties and immunotherapy

Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies

Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment

The Effects of Immune Microenvironment on Cancer Stem Cells

Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment

Intricate relationship between cancer stemness, metastasis, and drug resistance

Stem cell programs in cancer initiation, progression, and therapy resistance

Stemness in solid malignancies: coping with immune attack

Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets.

Cancer stem cells: advances in knowledge and implications for cancer therapy

Cancer Stem Cells: Therapeutic Implications and Perspectives in Cancer Therapy

The missing link between cancer stem cells and immunotherapy

Cancer stem cell–immune cell crosstalk in tumour progression

Cancer Stem Cells, Metabolism, and Therapeutic Significance

Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Targeting cancer stem cells in cancer therapy